These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26542552)

  • 1. PUBLIC HEALTH. Dengue vaccines at a crossroad.
    Wilder-Smith A; Gubler DJ
    Science; 2015 Nov; 350(6261):626-7. PubMed ID: 26542552
    [No Abstract]   [Full Text] [Related]  

  • 2. Tropical diseases. Dengue vaccine trial poses public health quandary.
    Normile D
    Science; 2014 Jul; 345(6195):367-8. PubMed ID: 25061184
    [No Abstract]   [Full Text] [Related]  

  • 3. Mosquito control might not bolster imperfect dengue vaccines.
    Paul R; Sousa C; Sakuntabhai A; Devine G
    Lancet; 2014 Nov; 384(9956):1747-8. PubMed ID: 25455246
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International Meeting.
    Torresi J; Tapia-Conyer R; Margolis H
    PLoS Negl Trop Dis; 2013; 7(9):e2261. PubMed ID: 24086776
    [No Abstract]   [Full Text] [Related]  

  • 5. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts.
    Normile D
    Science; 2013 Oct; 342(6157):415. PubMed ID: 24159024
    [No Abstract]   [Full Text] [Related]  

  • 6. Edging closer towards the goal of a dengue vaccine.
    Wilder-Smith A; Yoon IK
    Expert Rev Vaccines; 2016; 15(4):433-5. PubMed ID: 26881780
    [No Abstract]   [Full Text] [Related]  

  • 7. Critique of World Health Organization Recommendation of a Dengue Vaccine.
    Halstead SB
    J Infect Dis; 2016 Dec; 214(12):1793-1795. PubMed ID: 27496975
    [No Abstract]   [Full Text] [Related]  

  • 8. Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015¹. Safety of CYD-TDV dengue vaccine.
    Wkly Epidemiol Rec; 2015 Aug; 90(34):421-3. PubMed ID: 26298882
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges in reducing dengue burden; diagnostics, control measures and vaccines.
    Lam SK
    Expert Rev Vaccines; 2013 Sep; 12(9):995-1010. PubMed ID: 24053394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Vaccine: Considerations before Rollout in Colombia.
    Villabona-Arenas CJ; Ocazionez Jimenez RE; Jimenez Silva CL
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004653. PubMed ID: 27280803
    [No Abstract]   [Full Text] [Related]  

  • 11. Introducing a dengue vaccine to Mexico: development of a system for evidence-based public policy recommendations.
    Betancourt-Cravioto M; Kuri-Morales P; González-Roldán JF; Tapia-Conyer R;
    PLoS Negl Trop Dis; 2014; 8(7):e3009. PubMed ID: 25077478
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of benefits and risks associated with dengue vaccination at the individual and population levels: a dynamic modeling approach.
    Coudeville L; Baurin N; Olivera-Botello G
    Expert Rev Vaccines; 2018 Aug; 17(8):753-763. PubMed ID: 30063839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the potential of a candidate dengue vaccine with mathematical modeling.
    ; Beatty M; Boni MF; Brown S; Buathong R; Burke D; Coudeville L; Cummings DA; Edelman R; Farrar J; Focks DA; Gomes MG; Guignard A; Halstead S; Hombach J; Knerer G; Koelle K; Lam FC; Lang J; Longini I; Medlock J; Namgyal P; Powell M; Recker M; Rohani P; Standaert B; Struchiner C; Teyssou R; Wearing H
    PLoS Negl Trop Dis; 2012; 6(3):e1450. PubMed ID: 22479655
    [No Abstract]   [Full Text] [Related]  

  • 14. Dengue vaccines: state of the art.
    Swaminathan S; Batra G; Khanna N
    Expert Opin Ther Pat; 2010 Jun; 20(6):819-35. PubMed ID: 20384534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Points for Consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.
    Lim JK; Lee YS; Wilder-Smith A; Thiry G; Mahoney R; Yoon IK
    Expert Rev Vaccines; 2016; 15(4):529-38. PubMed ID: 26651238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanofi’s successful Phase 3 trials may lead to first-ever dengue vaccine in 2015.
    Hum Vaccin Immunother; 2014; 10(12):3427. PubMed ID: 25864560
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of Dengue vaccines. Introduction.
    Coller BA; Barrett AD; Thomas SJ
    Vaccine; 2011 Sep; 29(42):7219-20. PubMed ID: 21708208
    [No Abstract]   [Full Text] [Related]  

  • 18. Financing dengue vaccine introduction in the Americas: challenges and opportunities.
    Constenla D; Clark S
    Expert Rev Vaccines; 2016; 15(4):547-59. PubMed ID: 26690087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated vaccine: the first clinically approved dengue vaccine?
    Fink K; Shi PY
    Expert Rev Vaccines; 2014 Feb; 13(2):185-8. PubMed ID: 24350687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue Vaccine in Regions of Endemic Disease.
    Saville M; L'Azou M; Noriega F
    N Engl J Med; 2016 Apr; 374(14):1388-9. PubMed ID: 27050219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.